Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-16

Clinical Trial Update: Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial comparing topical rebamipide with topical betamethasone for oral ulcers in Behçet's disease is underway across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rebamipide (rebamipide)
  • betamethasone (betamethasone)

Snippet

Sponsor: Cairo University | Conditions: Oral Ulceration Due to Behçet's Disease | Phase 1, Phase 2 | Status: UNKNOWN